This combined COC containing DSG blocks the estrogen-mediated increase in SHBG more than other antiandrogenic progestins [74] and would not be the first choice for women with PCOS, mainly for those with biochemical hyperandrogenism. This evidence concerns the gene SHBG and hyperandrogenism.